|
Market Closed -
Toronto S.E.
16:00:00 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 4.920 CAD | -1.60% |
|
-2.38% | +69.07% |
| 09-24 | Medexus Pharmaceuticals Inc. - Shareholder/Analyst Call | |
| 08-11 | Medexus Pharmaceuticals Inc., Q1 2027 Earnings Call, Aug 11, 2026 |
| Market Cap | 155M 109M 96.37M 90.12M 82.13M 10.45B 157M 1.09B 422M 5.32B 407M 399M 17.09B | P/E 2027 * |
21.4x | P/E 2028 * | 5.94x |
|---|---|---|---|---|---|
| Enterprise Value | 155M 109M 96.37M 90.12M 82.13M 10.45B 157M 1.09B 422M 5.32B 407M 399M 17.09B | EV / Sales 2027 * |
0.95x | EV / Sales 2028 * | 0.79x |
| Free-Float |
93.53% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| MDP | Delayed | |
OTC Markets
| MEDXF | Delayed | |
|
Deutsche Boerse AG
| P731 | Delayed |
Last Transcript: Medexus Pharmaceuticals Inc.
| 1 day | -1.60% | ||
| 1 week | -2.38% | ||
| Current month | -1.60% | ||
| 1 month | -5.93% | ||
| 3 months | -3.53% | ||
| 6 months | +50.00% | ||
| Current year | +69.07% |
| 1 week | 4.86 |  | 5.13 |
| 1 month | 4.6 | | 5.27 |
| Current year | 2.65 | | 5.5 |
| 1 year | 2.51 | | 5.5 |
| 3 years | 1.44 | | 5.56 |
| 5 years | 0.88 | | 5.56 |
| 10 years | 0.88 | | 9.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2018-12-16 | |
Brendon Buschman
DFI | Director of Finance/CFO | - | 2019-05-31 |
| General Counsel | - | 2021-11-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mueller
CHM | Chairman | 66 | 2023-04-10 |
Benoit Gravel
BRD | Director/Board Member | - | 2017-09-21 |
| Director/Board Member | - | 2018-10-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/21/26 | Tax | Company | -1,000 | 0.0032% | - | |
| 8/21/26 | Tax | Company | 1,000 | 0.0032% | - | |
| 8/20/26 | Tax | Company | -8,100 | 0.0258% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.60% | -2.38% | +92.19% | +61.31% | 109M | |
| -0.62% | -2.71% | +39.30% | +114.07% | 1,025B | |
| -2.30% | -4.44% | +39.03% | +66.07% | 623B | |
| -0.63% | -1.96% | +6.36% | +74.38% | 459B | |
| -1.03% | -2.82% | +59.56% | +39.69% | 355B | |
| -0.36% | -3.39% | +22.44% | +40.33% | 336B | |
| -0.16% | -1.55% | +13.38% | +26.31% | 270B | |
| -0.47% | -4.46% | -3.71% | +9.52% | 247B | |
| -3.38% | +0.30% | +36.44% | +51.54% | 220B | |
| -1.04% | -1.46% | +32.70% | +96.82% | 183B | |
| Average | -0.89% | -1.94% | +33.77% | +58.01% | 371.83B | |
| Weighted average by Cap. | -0.65% | -2.11% | +30.37% | +69.50% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 163M 114M 102M 95.11M 86.67M 11.02B 165M 1.15B 445M 5.61B 430M 421M 18.03B | 197M 138M 122M 115M 104M 13.28B 199M 1.39B 536M 6.76B 518M 507M 21.72B |
| Net income | 7.47M 5.24M 4.65M 4.35M 3.97M 505M 7.57M 52.66M 20.39M 257M 19.68M 19.25M 825M | 26.89M 18.87M 16.76M 15.68M 14.28M 1.82B 27.26M 190M 73.41M 925M 70.85M 69.32M 2.97B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-01 | $4.920 | -1.60% | 24,832 |
| 26-09-30 | $5.000 | 0.00% | 56,784 |
| 26-09-29 | $5.000 | -2.34% | 38,303 |
| 26-09-28 | $5.120 | 0.00% | 15,975 |
| 26-09-25 | $5.120 | +1.59% | 22,901 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDP Stock
Select your edition
All financial news and data tailored to specific country editions
